TUESDAY, Nov. 12, 2024 -- For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in...
Vous n'êtes pas connecté
TUESDAY, Nov. 12, 2024 -- For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in recurrence, according to a study published online Oct. 30 in The BMJ. Natalie McCormick, Ph.D...
TUESDAY, Nov. 12, 2024 -- For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in...
TUESDAY, Nov. 12, 2024 -- For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor...
TUESDAY, Nov. 12, 2024 -- For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor...
THURSDAY, Nov. 14, 2024 -- More than one-third of patients admitted to the hospital for surgery have adverse events, with more than half potentially...
THURSDAY, Nov. 14, 2024 -- More than one-third of patients admitted to the hospital for surgery have adverse events, with more than half potentially...
FRIDAY, Nov. 15, 2024 -- Reducing sedentary behavior (SB) and increasing standing time at work is not associated with a reduction in blood pressure...
FRIDAY, Nov. 15, 2024 -- Reducing sedentary behavior (SB) and increasing standing time at work is not associated with a reduction in blood pressure...
WEDNESDAY, Nov. 13, 2024 -- Use of palliative care for heart failure remains low in the United States, according to a study recently published online...
WEDNESDAY, Nov. 13, 2024 -- Use of palliative care for heart failure remains low in the United States, according to a study recently published online...
THURSDAY, Nov. 14, 2024 -- Fasting at night prevents impairments in glucose tolerance among simulated night-shift work, according to a study published...